Brief: Addex Therapeutics FY Net Loss narrows to CHF 12.9 Mln
March 11 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* FY NET LOSS -12.9 MILLION CHF VERSUS -14.8 MILLION CHF
LOSS YEAR
AGO
* FY DILUTED LOSS PER SHARE 0.48 CHF VERSUS 0.56 CHF LOSS
YEAR AGO
* STRONG CASH AND CASH EQUIVALENTS POSITION AT DEC 31, 2020
OF
$20.2M (CHF18.7M)
Source text for Eikon: ID:nGNE3dK6Ky
Further company coverage: ADXN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand